BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 25799309)

  • 1. Overexpression of miR-155 in the liver of transgenic mice alters the expression profiling of hepatic genes associated with lipid metabolism.
    Lin X; Jia J; Du T; Li W; Wang X; Wei J; Lin X; Zeng H; Yao L; Chen X; Zhuang J; Weng J; Liu Y; Lin J; Wu Q; Wang W; Yao K; Xu K; Xiao D
    PLoS One; 2015; 10(3):e0118417. PubMed ID: 25799309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plant-derived polyphenols regulate expression of miRNA paralogs miR-103/107 and miR-122 and prevent diet-induced fatty liver disease in hyperlipidemic mice.
    Joven J; Espinel E; Rull A; Aragonès G; Rodríguez-Gallego E; Camps J; Micol V; Herranz-López M; Menéndez JA; Borrás I; Segura-Carretero A; Alonso-Villaverde C; Beltrán-Debón R
    Biochim Biophys Acta; 2012 Jul; 1820(7):894-9. PubMed ID: 22503922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalcoholic fatty liver disease is associated with an altered hepatocyte microRNA profile in LDL receptor knockout mice.
    Hoekstra M; van der Sluis RJ; Kuiper J; Van Berkel TJ
    J Nutr Biochem; 2012 Jun; 23(6):622-8. PubMed ID: 21764575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal high-fat diet consumption modulates hepatic lipid metabolism and microRNA-122 (miR-122) and microRNA-370 (miR-370) expression in offspring.
    Benatti RO; Melo AM; Borges FO; Ignacio-Souza LM; Simino LA; Milanski M; Velloso LA; Torsoni MA; Torsoni AS
    Br J Nutr; 2014 Jun; 111(12):2112-22. PubMed ID: 24666709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MacroH2A1 isoforms are associated with epigenetic markers for activation of lipogenic genes in fat-induced steatosis.
    Podrini C; Koffas A; Chokshi S; Vinciguerra M; Lelliott CJ; White JK; Adissu HA; Williams R; Greco A
    FASEB J; 2015 May; 29(5):1676-87. PubMed ID: 25526730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver specific inactivation of carboxylesterase 3/triacylglycerol hydrolase decreases blood lipids without causing severe steatosis in mice.
    Lian J; Wei E; Wang SP; Quiroga AD; Li L; Di Pardo A; van der Veen J; Sipione S; Mitchell GA; Lehner R
    Hepatology; 2012 Dec; 56(6):2154-62. PubMed ID: 22707181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lycopene inhibits hepatic steatosis via microRNA-21-induced downregulation of fatty acid-binding protein 7 in mice fed a high-fat diet.
    Ahn J; Lee H; Jung CH; Ha T
    Mol Nutr Food Res; 2012 Nov; 56(11):1665-74. PubMed ID: 22968990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-100 overexpression attenuates high fat diet induced weight gain, liver steatosis, hypertriglyceridemia and development of metabolic syndrome in mice.
    Smolka C; Schlösser D; Hohnloser C; Bemtgen X; Jänich C; Schneider L; Martin J; Pfeifer D; Moser M; Hasselblatt P; Bode C; Grundmann S; Pankratz F
    Mol Med; 2021 Sep; 27(1):101. PubMed ID: 34488621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dietary monosodium glutamate on HFCS-induced hepatic steatosis: expression profiles in the liver and visceral fat.
    Collison KS; Maqbool ZM; Inglis AL; Makhoul NJ; Saleh SM; Bakheet RH; Al-Johi MA; Al-Rabiah RK; Zaidi MZ; Al-Mohanna FA
    Obesity (Silver Spring); 2010 Jun; 18(6):1122-34. PubMed ID: 20111022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celastrus orbiculatus Thunb. ameliorates high-fat diet-induced non-alcoholic fatty liver disease in guinea pigs.
    Zhang Y; Si Y; Zhai L; Yang N; Yao S; Sang H; Zu D; Xu X; Qin S; Wang J
    Pharmazie; 2013 Oct; 68(10):850-4. PubMed ID: 24273892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of mitochondrial β-oxidation by miR-107 promotes hepatic lipid accumulation and impairs glucose tolerance in vivo.
    Bhatia H; Pattnaik BR; Datta M
    Int J Obes (Lond); 2016 May; 40(5):861-9. PubMed ID: 26499439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further reduction in adenovirus vector-mediated liver transduction without largely affecting transgene expression in target organ by exploiting microrna-mediated regulation and the Cre-loxP recombination system.
    Bennett D; Sakurai F; Shimizu K; Matsui H; Tomita K; Suzuki T; Katayama K; Kawabata K; Mizuguchi H
    Mol Pharm; 2012 Dec; 9(12):3452-63. PubMed ID: 23127182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice.
    Hasan ST; Zingg JM; Kwan P; Noble T; Smith D; Meydani M
    Atherosclerosis; 2014 Jan; 232(1):40-51. PubMed ID: 24401215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term adaptation of global transcription and metabolism in the liver of high-fat diet-fed C57BL/6J mice.
    Do GM; Oh HY; Kwon EY; Cho YY; Shin SK; Park HJ; Jeon SM; Kim E; Hur CG; Park TS; Sung MK; McGregor RA; Choi MS
    Mol Nutr Food Res; 2011 Sep; 55 Suppl 2():S173-85. PubMed ID: 21618427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain-specific natriuretic peptide receptor-B deletion attenuates high-fat diet-induced visceral and hepatic lipid deposition in mice.
    Yamashita Y; Yamada-Goto N; Katsuura G; Ochi Y; Kanai Y; Miyazaki Y; Kuwahara K; Kanamoto N; Miura M; Yasoda A; Ohinata K; Inagaki N; Nakao K
    Peptides; 2016 Jul; 81():38-50. PubMed ID: 27020246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fisetin protects against hepatosteatosis in mice by inhibiting miR-378.
    Jeon TI; Park JW; Ahn J; Jung CH; Ha TY
    Mol Nutr Food Res; 2013 Nov; 57(11):1931-7. PubMed ID: 23818290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-155 has a protective role in the development of non-alcoholic hepatosteatosis in mice.
    Miller AM; Gilchrist DS; Nijjar J; Araldi E; Ramirez CM; Lavery CA; Fernández-Hernando C; McInnes IB; Kurowska-Stolarska M
    PLoS One; 2013; 8(8):e72324. PubMed ID: 23991091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FABP4-Cre Mediated Expression of Constitutively Active ChREBP Protects Against Obesity, Fatty Liver, and Insulin Resistance.
    Nuotio-Antar AM; Poungvarin N; Li M; Schupp M; Mohammad M; Gerard S; Zou F; Chan L
    Endocrinology; 2015 Nov; 156(11):4020-32. PubMed ID: 26248218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-185 regulates expression of lipid metabolism genes and improves insulin sensitivity in mice with non-alcoholic fatty liver disease.
    Wang XC; Zhan XR; Li XY; Yu JJ; Liu XM
    World J Gastroenterol; 2014 Dec; 20(47):17914-23. PubMed ID: 25548489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.